Abstract
Recovery capital refers to the internal and external resources available to support an individual in their recovery from substance use disorders. Using data from an ongoing trial, the current study examined recovery capital among 225 individuals initiating office-based buprenorphine treatment for opioid use disorder (OUD) at Federally Qualified Health Centers in the mid-Atlantic region. At baseline, participants completed the Brief Assessment of Recovery Capital-10 (BARC-10), a validated measure assessing the 4 major domains of recovery capital and completed a urine toxicology screening. Participants reported BARC-10 scores of 49.22 on average (SD = 8.14). Average scores were highest for the item “I take full responsibility for my actions,” (M = 5.77, SD = .52), and lowest for “I am proud of the community I live in and feel a part of it” (M = 4.07, SD = 1.73). Lower recovery capital scores were associated with providing a urine screen suggestive of substance use, r(224) = -.16, p < .05 and reporting depression (B = -.06, p = .001) or anxiety (B = -.05, p < .05) in the past 30 days. By screening for recovery capital in individuals with OUD, providers may be able to more effectively tailor individuals’ behavioral treatment plans to positively impact their treatment outcomes.
Recommended Citation
Callahan, Hannah R.; Dugosh, Karen; Hurstak, Emily; McCarthy, Patty; Garber, Emily; DeJoseph, Daniel; DeJoseph, Julia; and Lent, Michelle R.
(2023)
"Recovery Capital, Mental Health and Substance Use among Individuals Initiating Office-Based Buprenorphine Treatment for Opioid Use Disorder,"
The Journal of Integrated Primary Care: Vol. 1:
Iss.
1, Article 4.
Available at:
https://digitalcommons.pcom.edu/jipc/vol1/iss1/4
Included in
Other Mental and Social Health Commons, Psychiatric and Mental Health Commons, Social and Behavioral Sciences Commons, Substance Abuse and Addiction Commons
